Survival Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Drug-Eluting Bead Chemoembolization
Survival Outcomes in Patients With Advanced Hepatocellular Carcinoma Treated With Drug-Eluting Bead Chemoembolization is organized by American Roentgen Ray Society (ARRS).
Date of issuance: January 23, 2015
Date of expiration: January 22, 2021
Estimated time to complete the activity: 1 hour(s)
The ARRS designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Goals and Objectives:
After completing the material in this article, the learner should be able to:
• Understand the criteria for tumor staging and treatment of hepatocellular carcinoma.
• Understand the treatment options and survival patterns of advanced hepatocellular carcinoma.
- CME : 1
The target audience for this activity is readers of the AJR, radiologists, radiologists-in-training, and other health professionals with an interest in treatment of hepatocellular carcinoma.
Number of Health Care Professionals Registered: 0 Number
Toll free Number
Browse CME / CE Conferences by Specialty View All
- Immunology and Microbiology
- Clinical Pharmacology
- Emergency Medicine
- Endocrinology, Metabolism and Diabetes
- Healthcare Management
- Infectious Disease
- Medical Education
- Obstetrics and Gynecology
- Pain Management
- Pharmacy and Medicine
- Primary Care
- Pulmonary Medicine